Genstar Capital Continues Expansion of Strategic Advisory Board With Addition of Harry Totonis

Genstar Capital Continues Expansion of Strategic Advisory Board With Addition
                               of Harry Totonis

Accomplished Leader Held Executive Positions at Surescripts, MasterCard and
Booz Allen & Hamilton

PR Newswire

SAN FRANCISCO, June 16, 2014

SAN FRANCISCO, June 16, 2014 /PRNewswire/ --Genstar Capital, a leading middle
market private equity firm that focuses on investments in targeted segments of
healthcare, software, financial services, and industrial
technologyindustries, today announced the appointment of Harry Totonis, an
experienced leader with a nearly 30 year track-record of success, to the
firm's Strategic Advisory Board (SAB).

Mr. Totonis most recently served as President and CEO of Surescripts, the
Nation's largest e-prescribing and clinical information exchange network,
since 2009. Prior to that, he was Group Executive at MasterCard Worldwide
from 2004 – 2009 and from 2000 – 2004 he served as President and CEO of
Kinexus. He began his professional career at Booz Allen & Hamilton and,
during his 15 years there, Mr. Totonis focused on strategy consulting for
large global companies at a CEO level. He is a graduate of The Ohio State
University and received an MBA in finance from Fisher College at Ohio State
University.

"Our Strategic Advisory Board includes an expert team of knowledgeable and
successful executives whose experience, expertise and relationship network
help us capitalize on new opportunities and manage our portfolio," said
Jean-Pierre L. Conte, Chairman and Managing Director of Genstar. "As we
continue to expand our portfolio of investments we are pleased to further
augment the talents of our investment professionals with seasoned executives
who have held senior leadership positions at prominent companies matched to
our investment focus. The business insights Harry has gained during his
extensive career will be very impactful, and we look forward to working with
him."

Genstar Capital's Strategic Advisory Board provides portfolio companies with a
rich source of operating experience and strategic insight, in addition to
advising the firm on our investments. The SAB is composed of influential
senior executives who are current or former leaders of major corporations.
These executives work directly with Genstar Capital and its portfolio
companies—sometimes as Board members—to develop strategic plans, expand market
opportunities, source acquisitions and recruit executives and board members.
Genstar's 20-member SAB includes executives who served in senior capacities
with such leading companies as Abbott Laboratories, Andersen Consulting,
UnitedHealthcare, CNA Insurance Companies, ITT Corporation, Oracle, Ingersoll
Rand, Marshall & Swift, MedImmune, WellPoint, Russell Investments, Siebel
Systems, USI, Vertifore and ICOS Corporation.

About Genstar Capital, LLC
Genstar Capital (www.gencap.com) is a leading private equity firm that has
been actively investing in high quality companies for more than 20 years.
Based in San Francisco, Genstar works in partnership with its management teams
and its network of operating executives and strategic advisors to transform
its portfolio companies into industry-leading businesses. Genstar has more
than $2.6 billion of committed capital under management and targets
investments focused on selected sectors within healthcare, software, financial
services and industrial technology industries.

Contact: Chris Tofalli
Chris Tofalli Public Relations
914-834-4334

SOURCE Genstar Capital, LLC

Website: http://www.gencap.com
 
Press spacebar to pause and continue. Press esc to stop.